<DrugInformationSummary id="CDR0000785931"><DrugInfoMetaData><DrugInfoType>Brief</DrugInfoType><DrugInfoAudience>Patients</DrugInfoAudience><DrugInfoDescription>This page contains brief information about rucaparib camsylate
         (Rubraca) and a collection of links to more information about the use of 
         this drug, research results, and ongoing clinical trials.
  </DrugInfoDescription><DrugInfoURL xref="https://www.cancer.gov/about-cancer/treatment/drugs/rucaparibcamsylate">Rucaparib Camsylate</DrugInfoURL><FDAApproved>Yes</FDAApproved><TerminologyLink ref="CDR0000785902">rucaparib camsylate</TerminologyLink><GlossaryLink ref="CDR0000785881">rucaparib camsylate</GlossaryLink><USBrandNames><USBrandName>Rubraca</USBrandName></USBrandNames><PronunciationInfo><TermPronunciation>roo-KA-puh-rib KAM-suh-layt</TermPronunciation><MediaLink ref="CDR0000786414" type="audio/mpeg" alt="" language="en" id="_3"/><MediaLink ref="CDR0000786413" type="audio/mpeg" alt="" language="es" id="_4"/></PronunciationInfo><FDAExternalRef xref="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a6d46c03-bb1d-417b-b8e5-3bffe352fe29&amp;audience=consumer">FDA label information for this drug is available at DailyMed.</FDAExternalRef></DrugInfoMetaData><DrugInfoTitle>Rucaparib Camsylate</DrugInfoTitle><Section id="_FDA"><Para><ExternalRef xref="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a6d46c03-bb1d-417b-b8e5-3bffe352fe29&amp;audience=consumer">FDA label information for this drug is available at DailyMed.</ExternalRef></Para></Section><Section id="_1"><Title>Use in Cancer</Title>                                                              
  <Para id="_2">Rucaparib camsylate
         is approved to treat:</Para>                          
  <ItemizedList Style="bullet" id="_3">
   
   
   <ListItem><Strong><GlossaryTermRef href="CDR0000046768" dictionary="Cancer.gov" audience="Patient">Ovarian epithelial</GlossaryTermRef>,</Strong> <Strong><GlossaryTermRef href="CDR0000755773" dictionary="Cancer.gov" audience="Patient">fallopian tube</GlossaryTermRef>,</Strong> or <Strong><GlossaryTermRef href="CDR0000386215" dictionary="Cancer.gov" audience="Patient">primary peritoneal cancer</GlossaryTermRef>.</Strong> It is used as <GlossaryTermRef href="CDR0000045768" dictionary="Cancer.gov" audience="Patient">maintenance therapy</GlossaryTermRef> in adults with <GlossaryTermRef href="CDR0000045862" dictionary="Cancer.gov" audience="Patient">recurrent</GlossaryTermRef> <GlossaryTermRef href="CDR0000045333" dictionary="Cancer.gov" audience="Patient">cancer</GlossaryTermRef> who are  having a <GlossaryTermRef href="CDR0000045652" dictionary="Cancer.gov" audience="Patient">complete</GlossaryTermRef> or <GlossaryTermRef href="CDR0000045819" dictionary="Cancer.gov" audience="Patient">partial response</GlossaryTermRef> to <GlossaryTermRef href="CDR0000045841" dictionary="Cancer.gov" audience="Patient">platinum</GlossaryTermRef> <GlossaryTermRef href="CDR0000045214" dictionary="Cancer.gov" audience="Patient">chemotherapy</GlossaryTermRef>. </ListItem><ListItem><Strong><GlossaryTermRef href="CDR0000445079" dictionary="Cancer.gov" audience="Patient">Prostate cancer</GlossaryTermRef></Strong> that is <GlossaryTermRef href="CDR0000044058" dictionary="Cancer.gov" audience="Patient">metastatic</GlossaryTermRef>, has a germline or somatic mutation in the <GeneName>BRCA1</GeneName> or <GeneName>BRCA2</GeneName> gene, and is <GlossaryTermRef href="CDR0000753525" dictionary="Cancer.gov" audience="Patient">castrate resistant</GlossaryTermRef> (has not responded to treatments that lower <GlossaryTermRef href="CDR0000045581" dictionary="Cancer.gov" audience="Patient">testosterone</GlossaryTermRef> levels). It is used in adults who have already been treated with <GlossaryTermRef href="CDR0000045251" dictionary="Cancer.gov" audience="Patient">antiandrogen therapy</GlossaryTermRef> and chemotherapy that included a <GlossaryTermRef href="CDR0000046138" dictionary="Cancer.gov" audience="Patient">taxane</GlossaryTermRef>.¹</ListItem></ItemizedList>
  <Para id="_11">¹This use is approved under FDA’s <ExternalRef xref="https://www.fda.gov/ForPatients/Approvals/Fast/ucm405447.htm">Accelerated Approval Program</ExternalRef>. As a condition of approval, <GlossaryTermRef href="CDR0000799146" dictionary="Cancer.gov" audience="Patient">confirmatory trial(s)</GlossaryTermRef> must show that rucaparib camsylate provides a clinical benefit in these patients.</Para><Para id="_4">Rucaparib camsylate
         is also being studied in the treatment of other types of
         cancer.</Para>
 </Section><Section id="_About"><Title>More About Rucaparib Camsylate</Title><Para id="_Dict_1"><ExternalRef xref="https://www.cancer.gov/publications/dictionaries/cancer-drug/def/785902">Definition from the NCI Drug Dictionary</ExternalRef> - Detailed scientific definition and other names for this drug.</Para>

<Para id="_About_8.16">MedlinePlus Information on <ExternalRef xref="https://medlineplus.gov/druginfo/meds/a617002.html">Rucaparib Camsylate</ExternalRef> - A lay language summary of important information about this drug that may include the following:</Para>
<ItemizedList Style="bullet" id="_About_9.17"><ListItem>warnings about this drug,</ListItem><ListItem>what this drug is used for and how it is used,</ListItem><ListItem>what you should tell your doctor before using this drug,</ListItem><ListItem>what you should know about this drug before using it, </ListItem><ListItem>other drugs that may interact with this drug, and</ListItem><ListItem>possible side effects.  </ListItem></ItemizedList><Para id="_About_10.18">Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for.  This patient information sheet applies only to approved uses of the drug.  However, much of the information may also apply to unapproved uses that are being studied.</Para></Section><Section id="_Research"><Title>Research Results and Related Resources</Title><Para><ExternalRef xref="https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies">Targeted Cancer Therapies</ExternalRef></Para></Section><Section id="_ClinicalTrial_1"><Title>Clinical Trials Accepting Patients</Title><Para id="_ClinicalTrial_2"><ExternalRef xref="https://www.cancer.gov/research/participate/clinical-trials/intervention/C131178">Find Clinical Trials for Rucaparib Camsylate</ExternalRef> - Check for trials from NCI's list of cancer clinical trials now accepting patients.</Para></Section> 
  <DrugInfoDisclaimer>


<Para id="_Disclaimer_4"><Strong>Important: </Strong>The drug information on this page is meant to be educational. It is not a substitute for medical advice. The information may not cover all possible uses, actions, interactions, or side effects of this drug, or precautions to be taken while using it. Please see your health care professional for more information about your specific medical condition and the use of this drug.
</Para></DrugInfoDisclaimer> 
  <DateFirstPublished>2017-01-03</DateFirstPublished><DateLastModified>2023-06-01</DateLastModified></DrugInformationSummary>
